Green Biologics Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Green Biologics Limited - overview

Established

2004

Location

Abingdon, England, UK

Primary Industry

Renewable Energy

About

Green Biologics Limited is a company focused on producing bio-based solvents, particularly acetone and dry cleaning solutions, catering to environmentally conscious sectors within beauty and cleaning industries. Founded in 2004 and headquartered in Abingdon, UK, Green Biologics Limited specializes in bio-based solvents and launched their flagship product, a bio-based acetone nail polish remover, in June 2018. The company raised USD 34 mn in VENTURE DEBT from Tennebaum Capital Partners on January 21, 2015, bringing their total amount raised to USD 42 mn. The firm has completed 10 deals to date.


Green Biologics Limited specializes in the production of bio-based solvents, focusing on eco-friendly acetone and dry cleaning solutions. Their flagship product, launched in June 2018, is a bio-based acetone nail polish remover that targets environmentally conscious consumers, primarily in the cosmetics and dry cleaning industries, with distribution across North America and Europe. In 2022, Green Biologics Limited reported a revenue of USD 0, while their EBITDA stood at USD -33,282. 7 for the same year.


Green Biologics Limited plans to leverage the recent funding to further develop its product line, with upcoming launches aimed at enhancing its portfolio of bio-based solvents. The company is also focused on expanding its market reach into new geographical areas in North America and Europe by 2025, capitalizing on the growing demand for sustainable products.


Current Investors

Capricorn Partners, Sofinnova Partners, Oxford Capital Partners, Carbon Trust, 5Y Capital, Rockley Group, Tennebaum Capital Partners, UK Department of Trade and Industry, Swire Pacific, Minnesota Department of Agriculture

Primary Industry

Renewable Energy

Sub Industries

Biomass, Commodity Chemicals, Paints & Coatings

Website

www.greenbiologics.com

Verticals

Clean Technology

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Green Biologics Limited - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Green Biologics Limited - financials

Fiscal Year EndedDec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Jun 30, 2019Jun 30, 2020Jun 30, 2021Jun 30, 2022Jun 30, 2023
Revenue (USD)24,575,527.9766,646,188.2681,492,493.856-2,564,996.8----
% Revenue Growth (YoY)-(73.0%)(77.5%)------
EBITDA (USD)(6,369,178.937)(7,781,915.234)(12,311,909.517)-(64,556,154.773)(640,723.44)---
Operating Income (USD)(8,738,314.546)(14,244,372.068)(17,417,605.201)-(74,285,985.96)(837,624.819)---
Operating Margin(35.6%)(214.3%)(1167.0%)-(2896.1%)----
% EBITDA Margin(25.9%)(117.1%)(824.9%)-(2516.8%)----
NET Income (USD)(11,149,989.884)(13,612,424.839)(17,561,263.559)-(72,317,607.88)(3,890,390.157)---
% Net Margin(45.4%)(204.8%)(1176.6%)-(2819.4%)----

Green Biologics Limited - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Unspecified RoundCompletedGreen Biologics Limited-
Venture DebtCompletedGreen Biologics Limited-
Add-onCompletedCentral Mn Ethanol Cooperative, LLC-
Trade SaleCompletedCentral Minnesota Ethanol Plant-
GrantCompletedGreen Biologics Limited-

Displaying 1 - 5 of 12

Green Biologics Limited - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.